VISTIN PHARMA ASA (VISTN.OL) Stock Price, Forecast & Analysis
Europe - OSL:VISTN - NO0010734122 - Common Stock
VISTN.OL Key Statistics, Chart & Performance
The current stock price of VISTN.OL is 20.3 NOK. In the past month the price decreased by -9.78%. In the past year, price decreased by -20.39%.
VISTN.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SAN.PA | SANOFI | 11.28 | 208.74B | ||
| SNW.DE | SANOFI | 11.24 | 208.11B | ||
| MRK.DE | MERCK KGAA | 12.97 | 47.99B | ||
| UCB.BR | UCB SA | 35.62 | 44.48B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| BAYN.DE | BAYER AG-REG | 5.24 | 25.79B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.41 | 10.47B | ||
| IPN.PA | IPSEN | 12.13 | 10.44B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 99.28 | 9.19B | ||
| VIRP.PA | VIRBAC SA | 20.01 | 2.91B | ||
| DMP.DE | DERMAPHARM HOLDING SE | 16.73 | 1.79B | ||
| MEDCL.PA | MEDINCELL SA | N/A | 1.03B |
Related stock screener links
About VISTN.OL
Company Profile
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
Company Info
VISTIN PHARMA ASA
Ostensjoveien 27
Oslo OSLO NO
Employees: 73
Phone: 4748926506
VISTIN PHARMA ASA / VISTN.OL FAQ
What does VISTN do?
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
What is the stock price of VISTIN PHARMA ASA today?
The current stock price of VISTN.OL is 20.3 NOK. The price increased by 2.78% in the last trading session.
What is the dividend status of VISTIN PHARMA ASA?
VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 5.9%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of VISTN stock?
VISTN.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the number of employees for VISTIN PHARMA ASA?
VISTIN PHARMA ASA (VISTN.OL) currently has 73 employees.
Can you provide the ownership details for VISTN stock?
You can find the ownership structure of VISTIN PHARMA ASA (VISTN.OL) on the Ownership tab.
VISTN.OL Technical Analysis
VISTN.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. While VISTN.OL has a great health rating, its profitability is only average at the moment.
VISTN.OL Financial Highlights
Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.72. The EPS increased by 11.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.84% | ||
| ROA | 18.05% | ||
| ROE | 25.86% | ||
| Debt/Equity | 0.14 |